| Record ID | marc_loc_2016/BooksAll.2016.part25.utf8:157538031:798 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part25.utf8:157538031:798?format=raw |
LEADER: 00798nam a2200253 a 4500
001 96143434
003 DLC
005 19960605112448.5
008 960501s1995 ctua 000 0 eng
010 $a 96143434
020 $a156965042X
040 $aDLC$cDLC
050 00 $aHD9660.E582$bR678 1995
100 10 $aRotheim, Philip.
245 10 $aBioengineered protein drugs :$benzymes /$cPhilip Rotheim, Sr. industry analyst.
260 $aNorwalk, CT :$bBusiness Communications Co.,$c1995.
300 $axix, 267 p. :$bill. ;$c28 cm.
440 0 $aBusiness opportunity report ;$vC-065NC
650 0 $aEnzymes industry.
650 0 $aProtein products industry.
650 0 $aProtein engineering.
650 0 $aBiotechnology industries.
650 0 $aMarket surveys.
710 2 $aBusiness Communications Co.